Liquidia Shareholders Back Directors, Auditor and Executive Pay
Claim 55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Liquidia Technologies ( (LQDA) ) has issued an update.
On June 16, 2026, Liquidia Corporation held its annual meeting of stockholders, at which shareholders voted on the election of three Class II directors, the ratification of its independent registered public accounting firm for 2026, and a non-binding advisory vote on executive compensation. A quorum was established with 67,479,187 shares represented, and all three Class II director nominees were elected to serve until the 2029 annual meeting or until their successors are duly elected and qualified.
Shareholders also strongly ratified the appointment of PricewaterhouseCoopers LLP as Liquidia’s independent registered public accounting firm for the year ending December 31, 2026, with an overwhelming majority voting in favor and minimal opposition or abstentions recorded. In addition, investors approved, on an advisory basis, the compensation of the company’s named executive officers, signaling support for Liquidia’s current governance, leadership structure, and financial oversight practices.
The most recent analyst rating on (LQDA) stock is a Buy
with a $75.00 price target.
To see the full list of analyst forecasts on Liquidia Technologies stock,
see the LQDA Stock Forecast page.
Spark’s Take on LQDA Stock
According to Spark, TipRanks’ AI Analyst, LQDA is a Neutral.
The score is driven primarily by improving financial performance and a very bullish earnings outlook supported by strong YUTREPIA launch metrics and consecutive profitable quarters. Technicals also reflect strong trend strength, though momentum is extended. The main offset is valuation risk, with an extremely high P/E making the stock more vulnerable to any execution or legal setbacks.
To see Spark’s full report on LQDA stock,
click here.
More about Liquidia Technologies
Liquidia Corporation is a biopharmaceutical company that develops and commercializes therapies, with a focus on drug delivery technologies and treatments targeting unmet needs in specialty disease markets. The company operates in a highly regulated industry where corporate governance decisions, including board composition, executive pay, and auditor selection, are closely watched by investors and other stakeholders.
Average Trading Volume: 1,498,855
Technical Sentiment Signal: Buy
Current Market Cap: $6.39B
Learn more about LQDA stock on TipRanks’ Stock Analysis page.
